(Q38059486)

28 August 2017

Efficacy and safety of ultra-long-acting insulin degludec (English)

1 reference

28 August 2017

Stephen L Atkin

2

0 references

author name string

Ammar Wakil

series ordinal

1

1 reference

28 August 2017

1 April 2012

1 reference

Therapeutic advances in endocrinology and metabolism

28 August 2017

1 reference

28 August 2017

3

1 reference

28 August 2017

2

1 reference

28 August 2017

55-59

1 reference

Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.

28 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474648

Correlates of insulin injection omission

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474648

A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474648

The underuse of insulin therapy in North America

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474648

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474648

How much do forgotten insulin injections matter to hemoglobin a1c in people with diabetes? A simulation study

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474648

Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474648

Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474648

Comment on: Tikhonenko et al. (2010) Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes;59:219-227.

31 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F2042018812437181

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23148194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/2042018812437181

1 reference

release_ub4mrn74rnga7mjtkl653pttca

28 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ub4mrn74rnga7mjtkl653pttca

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

3474648

1 reference

PMC publication ID

3474648

28 August 2017

PubMed publication ID

23148194

1 reference

PMC publication ID

3474648